SCHEMBL31191329

SCHEMBL31191329

OC(c1ccnc(OCC(F)F)c1)C(F)F

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ACACB O00763 19/20 0.38
▸ SYK P43405 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31191102 0.81 CYP2C9 (0.43) SYK
SCHEMBL19343284 0.80 ACACB (0.41) ACACB
SCHEMBL31191369 0.73 RECQL (0.46) ACACB
SCHEMBL25202663 0.73 ACACB (0.36) ACACB
SCHEMBL15034203 0.73 RXRA (0.42) ACACB
SCHEMBL20606987 0.73 ACACB (0.38) ACACB
SCHEMBL30281186 0.71 KDM4C (0.47) ACACB
SCHEMBL28976365 0.71 KDM4C (0.47) ACACB
SCHEMBL31191301 0.70 SYK (0.33) SYK
SCHEMBL10141646 0.70 ACACB (0.34) ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4702025-A1 BICYCLIC HETEROCYCLE COMPOUNDS FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2026-03-04 — — EP disclosed
WO-2024223715-A1 BICYCLIC HETEROCYCLE COMPOUNDS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2024-10-31 — — WO disclosed
Send feedback